Inactivation of Escherichia coli O157:H7 in Simulated Human Gastric Fluid
- 1 January 2005
- journal article
- Published by American Society for Microbiology in Applied and Environmental Microbiology
- Vol. 71 (1) , 320-325
- https://doi.org/10.1128/aem.71.1.320-325.2005
Abstract
Human disease caused by Escherichia coli O157:H7 is a function of the number of cells that are present at potential sites of infection and host susceptibility. Such infectious doses are a result, in part, of the quantity of cells that are ingested and that survive human host defenses, such as the low-pH environment of the stomach. To more fully understand the kinetics of E. coli O157:H7 survival in gastric fluid, individual E. coli O157:H7 strains were suspended in various media (i.e., saline, cooked ground beef [CGB], and CGB containing a commercial antacid product [CGB+A]), mixed at various proportions with simulated human gastric fluid (SGF), and then incubated at 37°C for up to 4 h. The highest inactivation rate among nine E. coli O157:H7 strains was observed in saline. Specifically, the average survival rates in 100:1 and 10:1 proportions of SGF-saline were −1.344 ± 0.564 and −0.997 ± 0.388 log 10 CFU/h, respectively. In contrast, the average inactivation rate for 10 E. coli O157:H7 strains suspended in 10:1 SGF-CGB was −0.081 ± 0.068, a rate that was 12-fold lower than that observed for SGF-saline. In comparison, the average inactivation rate for Shigella flexneri strain 5348 in 100:1 and 10:1 SGF-saline was −8.784 and −17.310, respectively. These latter inactivation rates were 7- to 17-fold higher than those for E. coli O157:H7 strains in SGF-saline and were 4-fold higher than those for E. coli O157:H7 strains in SGF-CGB. The survival rate of E. coli O157:H7 strain GFP80EC increased as the dose of antacid increased from one-half to twice the prescribed dose. A similar trend was observed for the matrix pH over the range of pH 1.6 to 5.7, indicating that pH is a primary factor affecting E. coli O157:H7 survival in SGF-CGB+A. These results can be used in risk assessment to define dose-response relationships for E. coli O157:H7 and to evaluate potential surrogate organisms.Keywords
This publication has 44 references indexed in Scilit:
- Acid stress responses in enterobacteriaFEMS Microbiology Letters, 2006
- The adaptive response of Escherichia coli O157 in an environment with changing pHJournal of Applied Microbiology, 2003
- Food-Related Illness and Death in the United StatesEmerging Infectious Diseases, 1999
- Omeprazole as a risk factor for campylobacter gastroenteritis: case-control studyBMJ, 1996
- Consensus Conference Statement: Escherichia coli O157:H7 infections—An Emerging National Health Crisis, July 11–13, 1994Gastroenterology, 1995
- A dynamic approach to predicting bacterial growth in foodInternational Journal of Food Microbiology, 1994
- Campylobacter jejuni non-culturable coccoid cellsInternational Journal of Food Microbiology, 1992
- Addendum to Response of Man to Infection with Vibrio choleraeThe Journal of Infectious Diseases, 1974
- Response of Man to Infection with Vibrio cholerae. I. Clinical, Serologic, and Bacteriologic Responses to a Known InoculumThe Journal of Infectious Diseases, 1974
- Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitroGut, 1972